Siren, L.L.C.
Filing Date
Global Rank
#662
/ 8,232
▲ 96
Top Industry
Biotechnology
93.1%
3Y Alpha vs SPY
+9.2%
Period ended 2 months ago
Filed May 14, 2026 · 30d
7 quarters · since Sep 2024
Clone Performance
Nov 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+43.4%
SPY
+27.3%
Annualised alpha
+9.2%
Max drawdown
−42.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
99 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
14.8%
+0.3 pts
Top 5
35.0%
+1.4 pts
Top 10
50.0%
+2.7 pts
HHI
433
Diversified+13
Portfolio Trend
7 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 93.6% | $3,360,957,936 |
| Technology | 3.7% | $133,189,061 |
| Communication Services | 1.7% | $61,587,576 |
| Consumer Cyclical | 0.8% | $27,874,460 |
| Industrials | 0.1% | $2,927,000 |
| Financial Services | 0.1% | $1,836,718 |
| Real Estate | 0.0% | $1,497,000 |
| Consumer Defensive | 0.0% | $941,500 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals, Inc. | +5,384,615 | 44,303,518 | $69,113,488 | |
| ERAS | Erasca, Inc. | +2,486,997 | 11,244,246 | $181,931,900 | |
| ZURA | Zura Bio Ltd | +2,434,866 | 3,734,866 | $22,222,452 | |
| ORIC | Oric Pharmaceuticals, Inc. | +1,990,617 | 2,998,192 | $37,987,092 | |
| ENGN | enGene Therapeutics Inc. | +1,916,895 | 5,253,159 | $35,774,012 | |
| OLMA | Olema Pharmaceuticals, Inc. | +1,456,249 | 4,756,949 | $70,926,109 | |
| BCAX | Bicara Therapeutics Inc. | +586,001 | 5,802,970 | $115,421,073 | |
| XENE | Xenon Pharmaceuticals Inc. | +505,803 | 1,318,564 | $76,674,496 | |
| FULC | Fulcrum Therapeutics, Inc. | +400,000 | 2,350,000 | $18,024,500 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | +396,000 | 1,903,636 | $69,140,059 | |
| GPCR | Structure Therapeutics Inc. | +250,000 | 1,328,698 | $64,043,243 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +225,536 | 725,511 | $63,097,691 | |
| PVLA | Palvella Therapeutics, Inc. | +182,485 | 257,485 | $32,095,505 | |
| CLBT | Cellebrite DI Ltd. | +161,544 | 311,544 | $4,293,076 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +115,000 | 1,615,476 | $101,290,345 | |
| COGT | Cogent Biosciences, Inc. | +80,000 | 1,709,279 | $65,790,148 | |
| MNPR | Monopar Therapeutics | +57,820 | 270,118 | $14,799,765 | |
| NVDA | Nvidia Corp | +51,600 | 89,085 | $15,536,424 | |
| NOW | ServiceNow, Inc. | +51,460 | 87,090 | $9,105,259 | |
| GOOGL | Alphabet Inc. | +45,000 | 65,703 | $18,893,554 | |
| NBIS | Nebius Group N.V. | +37,396 | 113,614 | $11,788,588 | |
| FROG | JFrog Ltd | +35,200 | 128,816 | $6,045,334 | |
| DT | Dynatrace, Inc. | +34,771 | 150,000 | $5,547,000 | |
| MSFT | Microsoft Corp | +26,380 | 41,380 | $15,317,634 | |
| FIG | Figma, Inc. | +25,000 | 50,000 | $1,057,000 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
18 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals plc | −2,974,053 | 1,053,464 | $41,843,590 | |
| TNGX | Tango Therapeutics, Inc. | −2,508,269 | 5,657,105 | $118,346,636 | |
| SEER | Seer, Inc. | −1,541,327 | 2,458,673 | $4,130,570 | |
| TSHA | Taysha Gene Therapies, Inc. | −1,300,000 | 8,829,913 | $39,469,711 | |
| DYN | Dyne Therapeutics, Inc. | −1,273,816 | 2,229,125 | $40,414,036 | |
| TRVI | Trevi Therapeutics, Inc. | −500,000 | 1,786,867 | $21,317,323 | |
| BCYC | Bicycle Therapeutics PLC | −451,870 | 1,560,882 | $7,242,492 | |
| STOK | Stoke Therapeutics, Inc. | −252,000 | 1,995,347 | $64,968,498 | |
| RVMD | Revolution Medicines, Inc. | −224,095 | 1,110,980 | $108,042,805 | |
| KYMR | Kymera Therapeutics, Inc. | −100,000 | 3,186,830 | $265,431,070 | |
| EWTX | Edgewise Therapeutics, Inc. | −99,727 | 4,430,263 | $139,553,284 | |
| RELY | Remitly Global, Inc. | −75,000 | 1,543,271 | $24,183,056 | |
| RAPP | Rapport Therapeutics, Inc. | −67,000 | 641,469 | $20,071,565 | |
| MDLN | Medline Inc. | −50,000 | 25,000 | $1,112,500 | |
| BEKE | KE Holdings Inc. | −45,000 | 100,000 | $1,497,000 | |
| ONC | BeOne Medicines Ltd. | −35,000 | 465,000 | $138,091,050 | |
| PRMB | Primo Brands Corp | −25,000 | 50,000 | $941,500 | |
| AMZN | Amazon Com Inc | −4,859 | 46,641 | $9,713,921 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
19 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MANE | Veradermics, Inc | 1,505,374 | $95,064,368 | |
| CYTK | Cytokinetics Inc | 613,952 | $40,465,576 | |
| ELVN | Enliven Therapeutics, Inc. | 746,226 | $29,252,059 | |
| DMRA | Damora Therapeutics, Inc. | 900,000 | $23,310,000 | |
| ANNX | Annexon, Inc. | 3,958,646 | $21,930,898 | |
| DFTX | Definium Therapeutics, Inc. | 919,493 | $17,378,417 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | 1,230,000 | $17,097,000 | |
| QURE | uniQure N.V. | 1,000,000 | $16,350,000 | |
| CTMX | CytomX Therapeutics, Inc. | 3,457,711 | $16,251,241 | |
| RZLT | Rezolute, Inc. | 3,328,287 | $10,151,275 | |
| GENB | Generate Biomedicines, Inc. | 736,104 | $9,201,300 | |
| ABSI | Absci Corp | 1,800,000 | $5,400,000 | |
| MSLE | Satellos Bioscience Inc. | 892,074 | $5,022,376 | |
| AGMB | Agomab Therapeutics NV | 411,250 | $4,314,012 | |
| FPS | Forgent Power Solutions, Inc. | 100,000 | $2,927,000 | |
| MU | Micron Technology Inc | 6,000 | $2,027,040 | |
| AS | Amer Sports, Inc. | 50,000 | $1,646,000 | |
| AEVA | Aeva Technologies, Inc. | 110,000 | $1,447,600 | |
| NU | Nu Holdings Ltd. | 25,000 | $359,250 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | 2,578,396 | $64,769,307 | |
| ASND | Ascendis Pharma A/S | 235,862 | $50,295,212 | |
| ZYME | Zymeworks Inc. | 1,680,121 | $44,237,585 | |
| MLYS | Mineralys Therapeutics, Inc. | 699,999 | $25,402,963 | |
| IHS | IHS Holding Ltd | 2,357,520 | $17,587,099 | |
| UPB | Upstream Bio, Inc. | 588,450 | $15,976,417 | |
| BNTC | Benitec Biopharma Inc. | 775,000 | $10,439,250 | |
| LXEO | Lexeo Therapeutics, Inc. | 720,622 | $7,155,776 | |
| CRM | Salesforce, Inc. | 26,100 | $6,914,151 | |
| CMPS | COMPASS Pathways plc | 1,000,000 | $6,900,000 | |
| BLLN | BillionToOne, Inc. | 83,833 | $6,860,892 | |
| SVRA | Savara Inc | 1,000,000 | $6,030,000 | |
| XFOR | X4 Pharmaceuticals, Inc | 1,500,000 | $6,000,000 | |
| ALMS | Alumis Inc. | 500,000 | $4,880,000 | |
| META | Meta Platforms, Inc. | 7,169 | $4,732,185 | |
| PEPG | PepGen Inc. | 700,000 | $4,557,000 | |
| SGMT | Sagimet Biosciences Inc. | 724,771 | $4,290,644 | |
| ADBE | Adobe Inc. | 12,051 | $4,217,729 | |
| EDU | New Oriental Education & Technology Group Inc. | 62,000 | $3,411,860 | |
| ZS | Zscaler, Inc. | 12,000 | $2,699,040 | |
| BDTX | Black Diamond Therapeutics, Inc. | 1,046,517 | $2,543,036 | |
| QCOM | Qualcomm Inc/De | 14,000 | $2,394,700 | |
| ARM | Arm Holdings PLC /Uk | 21,500 | $2,350,165 | |
| TIL | Instil Bio, Inc. | 203,933 | $2,243,263 | |
| PANW | Palo Alto Networks Inc | 11,450 | $2,109,090 | |
| No positions match the current search. | ||||
99 positions ·
$3,590,811,251 total
· as of Mar 31, 2026
All sectors
Communication Services
Consumer Cyclical
Consumer Defensive
Financial Services
Healthcare
Industrials
Real Estate
Technology
Showing 1–50
of 99 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Held | 10,825,013 | $532,157,639 | 14.82% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Reduced | 3,186,830 | $265,431,070 | 7.39% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 11,244,246 | $181,931,900 | 5.07% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 4,430,263 | $139,553,284 | 3.89% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Reduced | 465,000 | $138,091,050 | 3.85% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 5,657,105 | $118,346,636 | 3.30% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 5,802,970 | $115,421,073 | 3.21% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 1,110,980 | $108,042,805 | 3.01% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 1,615,476 | $101,290,345 | 2.82% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 1,505,374 | $95,064,368 | 2.65% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 1,318,564 | $76,674,496 | 2.14% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Added | 4,756,949 | $70,926,109 | 1.98% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 1,903,636 | $69,140,059 | 1.93% | |
| LXRX |
Lexicon Pharmaceuticals, Inc.
Healthcare
|
Added | 44,303,518 | $69,113,488 | 1.92% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 1,709,279 | $65,790,148 | 1.83% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 1,995,347 | $64,968,498 | 1.81% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Held | 3,007,077 | $64,952,863 | 1.81% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 1,328,698 | $64,043,243 | 1.78% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 988,401 | $63,198,359 | 1.76% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 725,511 | $63,097,691 | 1.76% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Held | 7,690,405 | $55,370,916 | 1.54% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 2,000,000 | $48,060,000 | 1.34% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Reduced | 1,053,464 | $41,843,590 | 1.17% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
Held | 818,598 | $41,290,083 | 1.15% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 613,952 | $40,465,576 | 1.13% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 2,229,125 | $40,414,036 | 1.13% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Reduced | 8,829,913 | $39,469,711 | 1.10% | |
| DBVT |
DBV Technologies S.A.
Healthcare
|
Held | 1,857,362 | $38,800,292 | 1.08% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 2,998,192 | $37,987,092 | 1.06% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Added | 5,253,159 | $35,774,012 | 1.00% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Added | 257,485 | $32,095,505 | 0.89% | |
| TBLA |
Taboola.com Ltd.
Communication Services
|
Held | 9,969,495 | $30,905,434 | 0.86% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
NEW | 746,226 | $29,252,059 | 0.81% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Held | 1,396,513 | $26,813,049 | 0.75% | |
| RELY |
Remitly Global, Inc.
Technology
|
Reduced | 1,543,271 | $24,183,056 | 0.67% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 900,000 | $23,310,000 | 0.65% | |
| ZURA |
Zura Bio Ltd
Healthcare
|
Added | 3,734,866 | $22,222,452 | 0.62% | |
| ANNX |
Annexon, Inc.
Healthcare
|
NEW | 3,958,646 | $21,930,898 | 0.61% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Reduced | 1,786,867 | $21,317,323 | 0.59% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Reduced | 641,469 | $20,071,565 | 0.56% | |
| GOOGL |
Alphabet Inc.
Communication Services
|
Added | 65,703 | $18,893,554 | 0.53% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Added | 2,350,000 | $18,024,500 | 0.50% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Held | 2,450,000 | $17,762,500 | 0.49% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 919,493 | $17,378,417 | 0.48% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
NEW | 1,230,000 | $17,097,000 | 0.48% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Held | 1,193,410 | $16,958,356 | 0.47% | |
| QURE |
uniQure N.V.
Healthcare
|
NEW | 1,000,000 | $16,350,000 | 0.46% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
NEW | 3,457,711 | $16,251,241 | 0.45% | |
| NVDA |
Nvidia Corp
Technology
|
Added | 89,085 | $15,536,424 | 0.43% | |
| SLN |
Silence Therapeutics plc
Healthcare
|
Held | 2,911,438 | $15,343,278 | 0.43% |